114 related articles for article (PubMed ID: 7608666)
1. Magnetic resonance spectroscopic study of parkinsonism related to boxing.
Davie CA; Pirtosek Z; Barker GJ; Kingsley DP; Miller PH; Lees AJ
J Neurol Neurosurg Psychiatry; 1995 Jun; 58(6):688-91. PubMed ID: 7608666
[TBL] [Abstract][Full Text] [Related]
2. Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy.
Federico F; Simone IL; Lucivero V; De Mari M; Giannini P; Iliceto G; Mezzapesa DM; Lamberti P
J Neurol Neurosurg Psychiatry; 1997 Mar; 62(3):239-42. PubMed ID: 9069478
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance spectroscopic study of parkinsonism related to boxing.
Chaudhuri KR; Lemmens G; Williams SC; Leigh PN
J Neurol Neurosurg Psychiatry; 1995 Nov; 59(5):561-2. PubMed ID: 8530957
[No Abstract] [Full Text] [Related]
4. Proton magnetic resonance spectroscopy in Parkinson's disease and atypical parkinsonian disorders.
Federico F; Simone IL; Lucivero V; Iliceto G; De Mari M; Giannini P; Mezzapesa DM; Tarantino A; Lamberti P
Mov Disord; 1997 Nov; 12(6):903-9. PubMed ID: 9399213
[TBL] [Abstract][Full Text] [Related]
5. MRS study on lentiform nucleus in idiopathic Parkinson's disease with unilateral symptoms.
Zheng XN; Zhu XC; Ruan LX; Zhang LJ; Yuan M; Shang DS; Liu Y
J Zhejiang Univ Sci; 2004 Feb; 5(2):246-50. PubMed ID: 14674041
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy.
Davie CA; Wenning GK; Barker GJ; Tofts PS; Kendall BE; Quinn N; McDonald WI; Marsden CD; Miller DH
Ann Neurol; 1995 Feb; 37(2):204-10. PubMed ID: 7847862
[TBL] [Abstract][Full Text] [Related]
7. Proton magnetic resonance spectroscopy in Steele-Richardson-Olszewski syndrome.
Davie CA; Barker GJ; Machado C; Miller DH; Lees AJ
Mov Disord; 1997 Sep; 12(5):767-71. PubMed ID: 9380064
[TBL] [Abstract][Full Text] [Related]
8. Localized proton NMR spectroscopy in the striatum of patients with idiopathic Parkinson's disease: a multicenter pilot study.
Holshouser BA; Komu M; Möller HE; Zijlmans J; Kolem H; Hinshaw DB; Sonninen P; Vermathen P; Heerschap A; Masur H
Magn Reson Med; 1995 May; 33(5):589-94. PubMed ID: 7596261
[TBL] [Abstract][Full Text] [Related]
9. Glutamate measurement in Parkinson's disease using MRS at 3 T field strength.
Kickler N; Krack P; Fraix V; Lebas JF; Lamalle L; Durif F; Krainik A; Rémy C; Segebarth C; Pollak P
NMR Biomed; 2007 Dec; 20(8):757-62. PubMed ID: 17334978
[TBL] [Abstract][Full Text] [Related]
10. Unchanged basal ganglia N-acetylaspartate and glutamate in idiopathic Parkinson's disease measured by proton magnetic resonance spectroscopy.
Clarke CE; Lowry M; Horsman A
Mov Disord; 1997 May; 12(3):297-301. PubMed ID: 9159722
[TBL] [Abstract][Full Text] [Related]
11. Multivariate analysis of regional metabolic differences in normal ageing on localised quantitative proton MR spectroscopy.
Harada M; Miyoshi H; Otsuka H; Nishitani H; Uno M
Neuroradiology; 2001 Jun; 43(6):448-52. PubMed ID: 11465755
[TBL] [Abstract][Full Text] [Related]
12. A comprehensive review of proton magnetic resonance spectroscopy studies in dementia and Parkinson's disease.
Firbank MJ; Harrison RM; O'Brien JT
Dement Geriatr Cogn Disord; 2002; 14(2):64-76. PubMed ID: 12145453
[TBL] [Abstract][Full Text] [Related]
13. Proton magnetic resonance spectroscopy in suspected vascular ischemic parkinsonism.
Zijlmans JC; de Koster A; van 't Hof MA; Thijssen HO; Horstink MW; Heerschap A
Acta Neurol Scand; 1994 Dec; 90(6):405-11. PubMed ID: 7892759
[TBL] [Abstract][Full Text] [Related]
14. Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonism.
Murray AM; Weihmueller FB; Marshall JF; Hurtig HI; Gottleib GL; Joyce JN
Ann Neurol; 1995 Mar; 37(3):300-12. PubMed ID: 7695230
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of proton and phosphorus MR spectroscopic imaging for early diagnosis of Parkinson's disease.
Weiduschat N; Mao X; Beal MF; Nirenberg MJ; Shungu DC; Henchcliffe C
J Neuroimaging; 2015; 25(1):105-10. PubMed ID: 24325203
[TBL] [Abstract][Full Text] [Related]
16. Proton Magnetic Resonance Spectroscopy Changes in Parkinson's Disease With and Without Psychosis.
Rodríguez-Violante M; Cervantes-Arriaga A; González-Latapí P; León-Ortiz P; de la Fuente-Sandoval C; Corona T
Rev Invest Clin; 2015; 67(4):227-34. PubMed ID: 26426588
[TBL] [Abstract][Full Text] [Related]
17. In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.
Hansen AK; Knudsen K; Lillethorup TP; Landau AM; Parbo P; Fedorova T; Audrain H; Bender D; Østergaard K; Brooks DJ; Borghammer P
Brain; 2016 Jul; 139(Pt 7):2039-49. PubMed ID: 27190023
[TBL] [Abstract][Full Text] [Related]
18. Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease.
Jin L; Wang J; Zhao L; Jin H; Fei G; Zhang Y; Zeng M; Zhong C
Brain; 2011 Jan; 134(Pt 1):50-8. PubMed ID: 21109502
[TBL] [Abstract][Full Text] [Related]
19. A short echo 1H spectroscopy and volumetric MRI study of the corpus striatum in patients with obsessive-compulsive disorder and comparison subjects.
Bartha R; Stein MB; Williamson PC; Drost DJ; Neufeld RW; Carr TJ; Canaran G; Densmore M; Anderson G; Siddiqui AR
Am J Psychiatry; 1998 Nov; 155(11):1584-91. PubMed ID: 9812122
[TBL] [Abstract][Full Text] [Related]
20. Phosphorus and proton magnetic resonance spectroscopy demonstrates mitochondrial dysfunction in early and advanced Parkinson's disease.
Hattingen E; Magerkurth J; Pilatus U; Mozer A; Seifried C; Steinmetz H; Zanella F; Hilker R
Brain; 2009 Dec; 132(Pt 12):3285-97. PubMed ID: 19952056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
